文献速递姑息放疗与转移瘤

姑息放疗对骨与非骨病灶患者生活质量的影响:前瞻性研究二次分析

Impact of Palliative Radiation Therapy on Quality of Life in Patients with Bone Versus Nonbone Lesions: Secondary Analysis of a Prospective Study.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-10-10

本研究基于440例678个病灶(541个骨转移、137个非骨病灶)的前瞻性队列,比较姑息放疗后生活质量变化。结论认为非骨病灶姑息放疗后生活质量变化与骨转移相当。

要点

  • 姑息放疗后12周,骨转移与非骨病灶两组全球健康状况/生活质量均分变化无显著差异。

核心结论

  • 非骨病灶姑息放疗后的生活质量变化与骨转移灶相当,为该领域后续研究提供依据。

研究设计与样本

  • 前瞻性研究二次分析,纳入2021至2023年接受姑息放疗的440例患者共678个病灶(541个骨转移、137个非骨病灶)。
  • 从2756份QLQ-C15-PAL/BM22问卷中分析基线及放疗后2、4、12周各子量表均分。
  • 主要终点为基线至12周全球健康状况/生活质量均分变化在两组间的差异。

临床怎么用

  • 非骨病灶所致疼痛可考虑姑息放疗,其生活质量获益与骨转移灶姑息放疗相当。
  • 骨转移患者放疗后需关注呼吸困难加重,非骨病灶组呼吸困难变化较小。

局限性

  • 为前瞻性研究的二次分析,非预设主要分析。
  • 12周时生活质量数据仅覆盖74%(338/458)病灶,存在失访。
  • 中位随访时间疼痛应答为21周、生活质量为13周。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study compared quality-of-life (QoL) changes following palliative radiation therapy (RT) between patients with painful bone metastases and those with painful nonbone lesions. METHODS AND MATERIALS: A total of 440 patients with 678 lesions (541 bone metastases and 137 nonbone lesions) who underwent palliative RT between 2021 and 2023 were included, using the same cohort as a previous study assessing pain response. From 2756 QLQ-C15-PAL/BM22 (Quality of Life Questionnaire Core 15 Palliative/ Bone Metastases Module) questionnaires collected simultaneously with pain assessments, mean scores for each C15-PAL (Core 15 Palliative) subscale at baseline and 2, 4, and 12 weeks post-RT were analyzed. The primary endpoint was the difference in mean change in global health status (GHS)/QoL scores from baseline to 12 weeks between the groups. Secondary endpoints included the differences in other subscales and the improvement rates in each subscale. RESULTS: The median follow-up time was 21 weeks for pain response and 13 weeks for QoL. Baseline QoL data were available for 97% (656/678) of lesions and 74% (338/458) at 12 weeks, with no significant difference between the groups. At baseline, the nonbone group had better GHS/QoL (45 vs 39, P = .015) and physical functioning (76 vs 67, P = .02), but slightly worse scores in the pain subscale (52 vs 51, P = .005). At 12 weeks, no significant differences were observed between the groups across all QoL subscales, including GHS/QoL (52 vs 49, P = .41). Regarding changes over time, dyspnea worsened in the bone metastasis group (+9 vs +1, P = .017), while changes in GHS/QoL (+5 vs +1, P = .27) and other subscales were not significantly different. Improvement rates across all subscales, including GHS/QoL (39% vs 48%, P = .44), were not significantly different between groups. CONCLUSIONS: The results of this study indicate that QoL changes after palliative RT for nonbone lesions are comparable to those for bone metastases, providing a basis for future development in this underexplored area.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Koide Y, Nimura K, Noguchi M, et al. Impact of Palliative Radiation Therapy on Quality of Life in Patients with Bone Versus Nonbone Lesions: Secondary Analysis of a Prospective Study. Int J Radiat Oncol Biol Phys. 2025. PMID: 41077310. doi:10.1016/j.ijrobp.2025.09.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。